A tumble, a tackle: Anything can bring on a sidelining sports injury. Now, four experts in such injuries at Penn State Health give advice on recovery and when it’s okay to return to play. AC shoulder sprains...

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says. First, blood cancers are far more common...

Over the past decade, rates of preterm birth in the United States jumped more than 10%, a new study of more than 5 million births shows. The rise dovetailed with an increase in some factors that make...

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they’ve long hoped for: A means...

In a sign that climate change may be fueling heat illnesses in kids, a new study reveals that such visits to two Texas children’s emergency rooms spiked 170% between 2012 and 2023. Study leader Dr. Taylor Merritt,...

Folks who depend on e-bikes and powered scooters to get around know they might get hurt, but they might be surprised by just how likely that really is. Rates of injury on the trendy transportation devices skyrocketed...

Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research shows. That risk was 36% higher in babies conceived through techniques such as in vitro fertilization (IVF). Some...

Grandma’s pill organizer. Fido’s pain medication. A tossed-away tissue. All are potential sources of opioid poisoning for young children, researchers at the New Jersey Poison Control Center report. Their five-year look at 230 cases of opioid exposure...

Patients with opioid use disorder who receive higher doses of a drug to treat their addiction are more likely to have positive results, a new study finds.  Daily doses of the drug buprenorphine is a standard treatment...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who’ve failed other medications, a new trial shows. The treatment, tulisokibart, spurred remission of symptoms in more than a quarter of patients,...